Published in Lancet Neurol on September 01, 2014
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Hum Vaccin Immunother (2015) 0.80
Natalizumab in the pediatric MS population: results of the Italian registry. BMC Neurol (2015) 0.78
Children with multiple sclerosis should not become therapeutic hostages. Ther Adv Neurol Disord (2016) 0.78
Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology (2017) 0.75
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices. Curr Neurol Neurosci Rep (2016) 0.75
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options. Neurol Ther (2016) 0.75
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology (2007) 4.23
The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol (2013) 3.13
Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med (2012) 2.90
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol (2010) 2.41
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol (2014) 2.37
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach. Ann Neurol (2009) 2.18
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol (2011) 2.12
CNS aquaporin-4 autoimmunity in children. Neurology (2008) 2.10
Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol (2010) 2.08
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology (2011) 1.99
Role of MRI in the differentiation of ADEM from MS in children. Neurology (2008) 1.94
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol (2011) 1.92
Natural history of multiple sclerosis with childhood onset. N Engl J Med (2007) 1.89
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med (2007) 1.77
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology (2013) 1.75
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol (2007) 1.73
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler (2012) 1.73
Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol (2008) 1.64
Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63
Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis. Mult Scler (2010) 1.63
Primary central nervous system vasculitis in children. Arthritis Rheum (2006) 1.62
Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol (2010) 1.61
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol (2013) 1.59
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology (2014) 1.54
Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions. Dev Med Child Neurol (2007) 1.52
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology (2013) 1.51
Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol (2009) 1.50
Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol (2009) 1.50
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain (2009) 1.50
High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology (2006) 1.44
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology (2013) 1.44
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol (2012) 1.43
Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler (2009) 1.41
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS. Neurology (2013) 1.39
Epstein-Barr virus in pediatric multiple sclerosis. JAMA (2004) 1.38
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Ann Neurol (2012) 1.32
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol (2013) 1.27
2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol (2012) 1.21
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler (2011) 1.20
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler (2012) 1.19
Lesion distribution in children with clinically isolated syndromes. Ann Neurol (2008) 1.17
HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology (2011) 1.11
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler (2010) 1.11
Geographic variations of multiple sclerosis in France. Brain (2010) 1.10
Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology (2007) 1.10
Central nervous system vasculitis in children. Curr Opin Rheumatol (2004) 1.07
Regional brain atrophy in children with multiple sclerosis. Neuroimage (2011) 1.07
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry (2013) 1.07
Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology (2010) 1.07
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol (2012) 1.04
Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr (2007) 1.04
MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology (2011) 1.02
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain (2007) 1.01
Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol (2009) 0.97
Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology (2006) 0.97
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology (2008) 0.97
Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology (2010) 0.95
Common viruses associated with lower pediatric multiple sclerosis risk. Neurology (2011) 0.95
The management of multiple sclerosis in children: a European view. Mult Scler (2010) 0.95
Natalizumab use in pediatric multiple sclerosis. Arch Neurol (2008) 0.94
Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology (2012) 0.93
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology (2014) 0.93
Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol (2011) 0.93
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis. Neuroimage (2012) 0.92
Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology (2010) 0.92
Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology (2006) 0.91
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol (2013) 0.91
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler (2012) 0.91
Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol (2011) 0.91
Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study. J Neurol (2012) 0.90
International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology (2013) 0.89
Natalizumab therapy for highly active pediatric multiple sclerosis. JAMA Neurol (2013) 0.88
White matter integrity and math performance in pediatric multiple sclerosis: a diffusion tensor imaging study. Neuroreport (2011) 0.88
Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics (2003) 0.88
Safety and efficacy of natalizumab in children with multiple sclerosis. Neurology (2010) 0.87
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders. Mult Scler (2012) 0.87
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases. Mult Scler (2013) 0.87
Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis. Neuropsychology (2013) 0.87
Future MRI tools in multiple sclerosis. J Neurol Sci (2013) 0.86
Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology (2013) 0.85
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler (2012) 0.85
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler (2013) 0.85
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Mult Scler (2011) 0.84
Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study. Neurol Sci (2005) 0.84
Development of a standardized MRI scoring tool for CNS demyelination in children. AJNR Am J Neuroradiol (2013) 0.84
Diffusion tensor imaging and cognitive speed in children with multiple sclerosis. J Neurol Sci (2011) 0.84
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis. Eur J Paediatr Neurol (2012) 0.83
Evidence for neuroprotection and remyelination using imaging techniques. Neurology (2007) 0.83
Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol (2013) 0.82